These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhibition of tau amyloid formation and disruption of its preformed fibrils by Naphthoquinone-Dopamine hybrid. Paul A; Viswanathan GK; Huber A; Arad E; Engel H; Jelinek R; Gazit E; Segal D FEBS J; 2021 Jul; 288(14):4267-4290. PubMed ID: 33523571 [TBL] [Abstract][Full Text] [Related]
5. Integrating in vitro and in silico approaches to evaluate the "dual functionality" of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils. Haj E; Losev Y; Guru KrishnaKumar V; Pichinuk E; Engel H; Raveh A; Gazit E; Segal D Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1565-1575. PubMed ID: 29634991 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylation regulates fibrillation of an aggregation core peptide in the second repeat of microtubule-binding domain of human tau. Inoue M; Kaida S; Nakano S; Annoni C; Nakata E; Konno T; Morii T Bioorg Med Chem; 2014 Nov; 22(22):6471-80. PubMed ID: 25440728 [TBL] [Abstract][Full Text] [Related]
7. Positional effects of phosphorylation on the stability and morphology of tau-related amyloid fibrils. Inoue M; Konno T; Tainaka K; Nakata E; Yoshida HO; Morii T Biochemistry; 2012 Feb; 51(7):1396-406. PubMed ID: 22304362 [TBL] [Abstract][Full Text] [Related]
8. Secondary nucleating sequences affect kinetics and thermodynamics of tau aggregation. Moore CL; Huang MH; Robbennolt SA; Voss KR; Combs B; Gamblin TC; Goux WJ Biochemistry; 2011 Dec; 50(50):10876-86. PubMed ID: 22085312 [TBL] [Abstract][Full Text] [Related]
9. Terminal Capping of an Amyloidogenic Tau Fragment Modulates Its Fibrillation Propensity. Arya S; Ganguly P; Arsiccio A; Claud SL; Trapp B; Schonfeld GE; Liu X; Lazar Cantrell K; Shea JE; Bowers MT J Phys Chem B; 2020 Oct; 124(40):8772-8783. PubMed ID: 32816481 [TBL] [Abstract][Full Text] [Related]
10. Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics Simulation. Liu H; Zhong H; Liu X; Zhou S; Tan S; Liu H; Yao X ACS Chem Neurosci; 2019 Dec; 10(12):4810-4823. PubMed ID: 31661961 [TBL] [Abstract][Full Text] [Related]
11. Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids. KrishnaKumar VG; Paul A; Gazit E; Segal D Sci Rep; 2018 Jan; 8(1):71. PubMed ID: 29311706 [TBL] [Abstract][Full Text] [Related]
12. Membrane-mediated fibrillation and toxicity of the tau hexapeptide PHF6. Fanni AM; Vander Zanden CM; Majewska PV; Majewski J; Chi EY J Biol Chem; 2019 Oct; 294(42):15304-15317. PubMed ID: 31439664 [TBL] [Abstract][Full Text] [Related]
13. Structural insights into the co-aggregation of Aβ and tau amyloid core peptides: Revealing potential pathological heterooligomers by simulations. Li X; Chen Y; Yang Z; Zhang S; Wei G; Zhang L Int J Biol Macromol; 2024 Jan; 254(Pt 2):127841. PubMed ID: 37924907 [TBL] [Abstract][Full Text] [Related]
14. Atomistic mechanism of polyphenol amyloid aggregation inhibitors: molecular dynamics study of Curcumin, Exifone, and Myricetin interaction with the segment of tau peptide oligomer. Berhanu WM; Masunov AE J Biomol Struct Dyn; 2015; 33(7):1399-411. PubMed ID: 25093402 [TBL] [Abstract][Full Text] [Related]
15. Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer's disease-like symptoms in animal model. Viswanathan GK; Shwartz D; Losev Y; Arad E; Shemesh C; Pichinuk E; Engel H; Raveh A; Jelinek R; Cooper I; Gosselet F; Gazit E; Segal D Cell Mol Life Sci; 2020 Jul; 77(14):2795-2813. PubMed ID: 31562564 [TBL] [Abstract][Full Text] [Related]
16. Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease. Dammers C; Yolcu D; Kukuk L; Willbold D; Pickhardt M; Mandelkow E; Horn AH; Sticht H; Malhis MN; Will N; Schuster J; Funke SA PLoS One; 2016; 11(12):e0167432. PubMed ID: 28006031 [TBL] [Abstract][Full Text] [Related]
17. Identification of Aggregation Mechanism of Acetylated PHF6* and PHF6 Tau Peptides Based on Molecular Dynamics Simulations and Markov State Modeling. Shah SJA; Zhang Q; Guo J; Liu H; Liu H; Villà-Freixa J ACS Chem Neurosci; 2023 Nov; 14(21):3959-3971. PubMed ID: 37830541 [TBL] [Abstract][Full Text] [Related]
18. Selective Inhibition of Aggregation and Toxicity of a Tau-Derived Peptide using Its Glycosylated Analogues. Frenkel-Pinter M; Richman M; Belostozky A; Abu-Mokh A; Gazit E; Rahimipour S; Segal D Chemistry; 2016 Apr; 22(17):5945-52. PubMed ID: 26891276 [TBL] [Abstract][Full Text] [Related]
19. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange. Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067 [TBL] [Abstract][Full Text] [Related]
20. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases. Kreutzer AG; Nowick JS Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]